Skip to main content
. 2017 Jul 1;33(12):1931–1938. doi: 10.1007/s10554-017-1210-3

Table 2.

Procedural and echocardiographic data after the procedure

All patients
N = 148
PH (−)
N = 83
PH (+)
N = 65
P value
General anesthesia 98 (69.5) 53 (67.1) 45 (72.6) 0.48
Access type, n (%) 0.83
 Transfemoral 117 (79.1) 66 (79.5) 51 (78.5)
 Transapical 28 (18.9) 16 (19.3) 12 (18.5)
 Transaortic 2 (1.4) 1 (1.2) 1 (1.5)
 Subclavian 1 (0.7) 0 (0.0) 1 (1.5)
Device implanted, n (%) 0.41
 Corevalve/Evolut R, n (%) 29 (19.6) 18 (21.7) 11 (16.9)
 Edwards Sapien 95 (64.2) 48 (57.8) 47 (72.3)
 Jena 10 (6.8) 7 (8.4) 3 (4.6)
 Lotus 9 (6.1) 7 (8.4) 2 (3.1)
 NVT 5 (3.4) 3 (3.6) 2 (3.1)
Prosthesis size, n (%) (mm) 0.82
 23 30 (20.3) 18 (21.7) 12 (18.5)
 25 8 (5.4) 5 (6.0) 3 (4.6)
 26 56 (37.8) 29 (34.9) 27 (41.5)
 27 8 (5.4) 5 (6.0) 3 (4.6)
 29 38 (25.7) 23 (27.7) 15 (23.1)
 31 8 (5.4) 3 (3.6) 5 (7.7)
Prosthesis size, median (IQR) (mm) 26.0 (25.0–29.0) 26.0 (25.0–29.0) 26.0 (26.0–29.0) 0.74
TG max after TAVI, median (IQR) (mmHg) 13.0 (10.0–19.0) 12.8 (10.0–19.0) 15.0 (10.1–19.0) 0.21
TG mean after TAVI, median (IQR) (mmHg) 7.4 (5.1–10.0) 7.0 (5.0–10.5) 8.0 (6.0–10.0) 0.29
LVEF after, median (IQR) (%) 48.0 (41.0–55.0) 47.0 (40.0–50.0) 50.0 (45.0–60.0) 0.15
AR after, n (%) 0.041
 0 84 (56.8) 45 (54.2) 39 (60.0)
 1 55 (37.2) 35 (42.2) 20 (30.8)
 2 7 (4.7) 1 (1.2) 6 (9.2)
 3 2 (1.4) 2 (2.4) 0 (0.0)
Radiation dose, median (IQR) (mGy) 721.0 (632.5–827.5) 721.0 (634.0–826.0) 721.0 (631.0–823.0) 0.83
Contrast medium load, median (IQR) (ml) 75.0 (50.0–137.5) 75.0 (50.0–100.0) 75.0 (75.0–150.0) 0.07
Fluoroscopy time, median (IQR) (min) 13.0 (12.0–15.0) 13.0 (11.5–15.0) 13.0 (12.0–14.0) 0.62

AR aortic regurgitation, LVEF left ventricle ejection fraction, TG transaortic gradient